Table I.1: The Number of State Pharmacy Regulatory Bodies Reporting That Their Office Has Primary Responsibility for the Oversight of Drug Compounding for Human Use
Type of drug compounder Number of states (%)
  Yes No No response
Drug compounding by pharmacies and pharmacists 50 (100) 0 (0) 0 (0)
Drug compounding by Food and Drug Administration registered outsourcing facilities 35 (70) 13 (26) 2 (4)
Drug compounding by physicians 7 (14) 41 (82) 2 (4)
Drug compounding by other nonpharmacist health care practitioners (e.g., nurse practitioners, physician assistants) 8 (16) 41 (82) 1 (2)

Source: GAO survey of state pharmacy regulatory bodies, survey question 2. | GAO-17-363SP
Note: GAO surveyed the state pharmacy regulatory bodies in the 50 states, the District of Columbia, Guam, Puerto Rico, and the U.S. Virgin Islands, and all but 4 completed the survey.